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Abstract
There are unique challenges in managing patients with Continuous Subcutaneous Insulin Infusion (CSII) in the
inpatient setting, but these challenges may be mitigated by institutional protocols and staff education. The purpose
of our study was to determine the current level of patient satisfaction with the staff’s adherence with anthe insulin
pump policy and to identify areas for improvement. We hypothesize that the majority of patients will be satisfied with
inpatient CSII management, as our institute’s insulin pump policy had been implemented with educational sessions
one year prior. We created a 20- question survey to assess patient satisfaction in regards to their inpatient CSII
management which is governed by a system-wide insulin pump policy. 50 adult patients with both type 1 and type
2 diabetes managed with insulin pumps admitted to the hospital for medical care were surveyed. Fisher’s exact
test was used to measure the association between categorical variables and satisfaction. Of those surveyed, 78%
were satisfied with CSII management in the hospital. However, only 62% of participants answered favorably to the
statement which evaluated Emergency Department (ED) staff communication regarding the current insulin pump
policy. Therefore, targeted education to Emergency Department (ED) staff regarding the availability of an insulin
pump protocol and nursing measures to limit CSII disconnection time may further improve patient satisfaction.

Keywords: Satisfaction; Inpatient; Continuous subcutaneous insulin
infusion; Insulin pump; Type 2 Diabetes

Introduction
Over 21 million people in the United States have been diagnosed with
diabetes while an estimated 8.1 million people remain undiagnosed [1].
In addition, greater than 40% of all health care expenditures attributed
to diabetes resulted from higher rates of hospital admission and longer
average lengths of stay per admission [2]. The direct and indirect costs
associated with diabetes are staggering, thus appropriate inpatient
management of hyperglycemia is of utmost importance. Meta-analyses
have shown improved glycemic control with CSII over multiple daily
injections, specifically in patients with worsening baseline hemoglobin
A1C values [3]. CSII therapy has emerged as an important modality
in the treatment of patients with diabetes in the outpatient setting
owing to improvements in quality of life, patient autonomy, as well
as modest improvements in glucose control. However, evidence to
support the role of CSII therapy in the inpatient setting is not yet
established as advances and complexities of pump therapy may not be
fully understood by general inpatient providers.
In 2009, Sampson et al. published the first psychometrically
validated Diabetes Treatment Satisfaction Questionnaire for inpatients (DTSQ-IP) in the United Kingdom [4]. To date, no equivalent
studies have been done in the United States. Cook, et al. has developed
specific metrics (i.e. length of stay, number of hypoglycemic events,
number of hyperglycemic events) to measure effectiveness [5] but
excluded measures of patient satisfaction. The utility of a validated inpatient assessment tool are several-fold as results may identify factors
that result in variable glycemic control and prolong length of stay while
monitoring adverse events.
The Joint Commission accredits more than 20,500 healthcare
organizations nationwide. Hospitals with earned accreditation status
are nationally recognized as leaders in care delivery. Such institutions
are critically evaluated and held accountable to providing safe and
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effective care of the highest quality and value [5]. In order to maintain
disease-specific accreditation, non-standardized performance
measures such as patient satisfaction are established to allow programs
to systematically evaluate clinical processes and/or outcomes of disease
specific clinical practice guidelines. Having an insulin pump policy
is also a standard, and is a requirement for certification of inpatient
diabetes management by the Joint Commission [6]. Furthermore,
the challenge of performance feedback and objective assessment
continue to exist as there are few quantitative performance evaluation
tools to measure such outcomes. In the hospital, no single laboratory
test can accurately represent the overall quality of glycemic control.
Standardized glucose performance metrics (or “glucometrics”) in
the hospital setting include multiple glucose results obtained during
a variety of clinical situations including fasting and nutritional
conditions [7]. Although “Glucometrics” has emerged as a marker of
successful inpatient management, The National Committee of Quality
Assurance for Diabetes Quality Improvement Project (DQIP) has
proposed that patient satisfaction can also be an indicator to assess the
quality of diabetes care in the United States [8].
As a result, a CSII policy was implemented at our institution and
throughout our health system in March 2013. At that time, a mandatory
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education module and/or lectures was conducted with nurses, midlevel providers, residents and attending physicians. During the six
months after the policy was implemented, there were fewer recurrences
of hypoglycemia as compared to the six months prior to the policy.
That is, of the 30 patients in the pre-intervention group who had at
least one hypoglycemic event, 56.7% [9] had a recurrent event, wheras
of the 23 patients in the post-intervention period who had at least
one hypoglycemic event, 52.2% [10] had a recurrent event [11]. The
policy ensures that all patients admitted with CSII are assessed by the
endocrinology consult team, utilize hospital insulin and glucometer
systems, have three sets of infusion kits and complete a patient selfassessment with attestation forms indicating their understanding of
the CSII policy. Patients are also responsible for reporting to nurses
when they are changing their tubing/reservoir, suspending the pump,
and the daily bolus insulin doses, as well as carbohydrates consumed.
Nurses are then required to document these values and the status of the
patient’s insulin pump infusion skin site. A year later, a peri-operative
CSII pump policy was also devised in order to make patients aware of
the CSII policy prior to surgery and to ensure that they brought extra
supplies, set a temporary basal rate, or prepare by transitioning to SQ
insulin in the case of long or late-day procedures [10,11].
At North Shore University Hospital in Manhasset (NSUH), NY,
patients with Type I (n=34), Type 1.5 (n=1) or Type 2 (n=14) diabetes
utilizing outpatient CSII are permitted to stay on CSII during admission
if the patient or caregiver can be responsible for management 24 hours
per day. The goal of this study was to develop a patient questionnaire
that would allow us to determine patient satisfaction in regards to
staff’s adherence to admission and post-admission protocols while also
identifying areas for improvement.

Research Design and Methods
North Shore University Hospital is a 768 bed quaternary hospital
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with Joint Commission Certification in Diabetes. A year before
receiving this certification, an insulin pump policy was created to allow
patients to use CSII while admitted to our hospital. Prior to policy
implementation, education was provided to nurses, mid-levels and
physicians in regard to the policy in the form of on-line modules and
lectures conducted by the Inpatient Diabetes Team.
A survey (Figure 1) comprised of 20 questions was given to all
patients admitted to NSUH from February 2014 until October 2014
with an insulin pump who remained on their pump or initiated their
pump during their inpatient stay. It was developed based on our
current insulin pump policy and questions were constructed to assess
adherence to current pump policy as well as the patient’s satisfaction
with their diabetes care as it relates to CSII management. This
information would allow us to identify policy knowledge deficiencies
by staff while providing opportunities to improve upon our annual
educational training initiatives. Results are based on our pilot survey
group of n=50.
Patients were admitted to the medical or surgical units for various
diagnoses including chest pain, rule out Acute Coronary Syndrome
(ACS), foot ulcers and post cardiac catheterization. Length of stay was
not obtained for our study purposes, as this was a cross-sectional study.
The attending endocrinologist, certified diabetes educator or a medical
resident, distributed the surveys. The certified diabetes educator
(A.M.H) had access to a list of all patients with insulin pump orders
placed in our electronic medical record. Nurses were also encouraged
to notify A.M.H. upon admission of a patient with CSII to ensure
patient safety. Surveys were stored in the file cabinet of a locked office
inside of a locked medical suite. In order to further ensure patient
privacy, all surveys were de-identified with a link only available to
study coordinators.
Inclusion criteria were adults aged 18 years or older with Type 1, 1.5

The staff in the emergency room made me aware of the hospital insulin pump policy
The doctors on the floor understand how to handle my insulin pump
My doctor asked me what my bolus and basal insulin rates were
I came to the hospital because my pump (or its parts) were broken
It was easy to get insulin when I needed to change my pod or reservoir
My pump was not disconnected for more than 1 hour
My fingersticks were taken when my meals arrived
I completed the insulin pump self-assessment and attestation form within the first 2 days of my
hospitalization
The nurses asked how much insulin I gave myself before meals
The nursing staff checked my blood sugar at least 4 times a day
The doctor looked at my infusion site daily
My pump was disconnected when I went for an Xray, MRI, CT scan
My blood sugars are controlled better in the hospital as compared to using insulin injections
I prefer to not use my insulin pump when in the hospital
I am generally satisfied with my diabetes management in the hospital
The endocrinologist was comfortable in managing my pump settings
I met with the diabetes educator at least once during my stay
If my glucose was < 70 or > 200, I let doctors or nursing staff know
I experienced NO adverse events related to my insulin pump
The nurses looked at my infusion site daily
Figure 1: Patient Satisfaction Questionnaire.
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or 2 Diabetes. Exclusion criteria were patients under 18 or those who
could not use their pump during the entire length of their admission
due to missing CSII supplies, impaired cognition or suicidal ideation.
In addition, patients were allowed to refuse to participate (n=0).
Patients were asked to rate their satisfaction of the hospital staff’s
management of the CSII pump based on a five-level Likert scale.
Included in this survey were specific questions to ensure adherence to
pump policy including infusion site assessment by both the physician
and nurse providers, timing of point of care fingersticks at the time
of meal arrival, frequency of blood glucose checks and appropriate
recording of results based on a four times a day schedule. The order of
questions posed was not randomized.
The questionnaire was distributed to 50 patients admitted to our
facility. Given the descriptive nature of the study, the sample size of
50 was based on feasibility and availability of resources given the study
time frame. The 20-item survey measured patient’s perception of care
by emergency department (ED) staff, nursing staff, physicians, diabetes
educators as well as the convenience of CSII use in the hospital. The
following demographic and clinical demographic parameters were
obtained from patients: age, sex, diabetes type, race, HbA1c, number
of hospital admissions in the past year, insulin prescriber, pump type,
home insulin regimen, and associated complications from diabetes
(retinopathy; neuropathy; foot ulcers; nephropathy; CAD or stroke;
peripheral vascular disease) (Table 1). No participants refused to
partake in the survey and 4 patients were discharged prior to completing
the survey.

no adverse events related to my insulin pump,” 90% agreed/strongly
agreed, 8% disagreed/strongly disagreed, and 2% remained neutral.
Statements that were endorsed with “Strongly disagree” and/or
“disagree” at a rate greater than twenty five percent were identified as
potential areas for improvement. One area that was identified was in
Patient Characteristics

n (%)

Type of Diabetes (total respondents n = 49)
Type 1

34 (69.4)

Type 1.5

1 (2.04)

Type 2

14 (28.6)

Age in years (total respondents n = 49)
18-30

6 (12.2)

31-40

9 (18.4)

41-50

6 (12.2)

51-60

15 (30.6)

Over 61

13 (26.5)

Sex (total respondents n = 50)
Male

25 (50.0)

Female

25 (50.0)

A1c Range (total respondents n = 42)
Less than 6%

5 (11.9)

6-7%

10 (23.8)

7-8%

12 (28.6)

8-9%

12 (28.6)

10-12%

2 (4.76)

> 12%

1 (2.38)

Statistical analysis

Duration of Pump Use (total respondents n=50)

Frequencies and percents were tabulated for all demographic,
clinical and questionnaire items. Fisher’s exact test was used to measure
the association between categorical or ordinal variables and patient
satisfaction. Cronbach’s coefficient alpha was used to determine interitem reliability. An alpha level of less than 0.05 was used to declare
significance. SAS for Windows version 3.2 (SAS Institute Inc., Cary,
NC) was used to carry out the analysis.

6 months-1 year

5 (10.0)

1-5 years

23 (46.0)

6-10 years

13 (26.0)

11-15 years

5 (10.0)

> 16 years

3 (6.00)

Results
Of the 50 patients surveyed, 25 were male and 25 were female. The
majority (57%) of our patients were 51-60 years old, Caucasian (59.2%
Caucasian, 20% Black, 14.3% Hispanic Non-Black, 4.1% American
Indian and 2% “Other”). The range of HbA1c levels was between less
than 6% to greater than 12%. While 81% of patients reported HbA1c
levels of between 6 and 9%. Over half (65.3%) of patients had 0 or 1
hospital admission in the past year and the remaining patients had
between 2 to 7 admissions during that time. Forty-six percent of
patients had been using their insulin infusion pumps for 1-5 years.
Most patients used ultra-rapid acting insulin, only 6 patients (12.8%)
reported using Insulin U500. Of the patients who reported experiencing
complications of diabetes, neuropathy was cited as the most common
(50%) complication followed by 35.4% of patients who had associated
retinopathy.
As a whole, the 20-item questionnaire demonstrated acceptable
internal consistency with a Cronbach’s alpha of 0.73 [12,13]. Out of 50
patients surveyed, 78% responded “Agree” or “Strongly Agree” to the
statement, “I am generally satisfied with my diabetes management in the
hospital,” 6% of patients disagreed, and the remaining 16% remained
neutral in their responses. No patient “Strongly Disagreed” with the
statement. When asked to respond to the statement, “I experienced
J Diabetes Metab
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< 6 months

1 (2.00)

Number of Hospital Admission in the Past Year (total
respondents n = 49)
0-1

32 (65.3)

2-4

16 (32.7)

5-7

1 (2.04)

Diabetic Retinopathy (total respondents n = 48)
Yes

17 (35.4)

No

31 (64.6)

Diabetic Neuropathy (total respondents n = 48)
Yes

24 (50.0)

No

24 (50.0)

Diabetic Foot Ulcers (total respondents n = 49)
Yes

10 (20.4)

No

39 (79.6)

Diabetic Nephropathy (total respondents n = 47)
Yes

15 (31.9)

No

32 (68.1)

Patients with CAD1 or Stroke (total respondents n = 48)
Yes

10 (20.8)

No

38 (79.2)

Patients with PVD2
(total respondents n = 48)
Yes

10 (20.8)

No

38 (79.2)

1. CAD = Coronary Artery Disease
2. PVD = Peripheral Vascular Disease
Table 1: Patient Dempographics.

Volume 6 • Issue 10 • 1000619

Citation: Kim TS, Kline M, Hasse AM, Myers AK (2015) Assessing Patient Satisfaction of Providers’ Adherence to Inpatient Management with
Continuous Subcutaneous Insulin Infusion (CSII) Policy: A Cross-Sectional Study. J Diabetes Metab 6: 619. doi:10.4172/2155-6156.1000619

Page 4 of 5
the Emergency Department (ED) where 29% of patients responded
“Disagree/Strongly Disagree” to the statement “The staff in the ED
made me aware of the hospital insulin pump policy” (Table 2). The
second area for targeted intervention pertained to CSII disconnection
time. Twenty-nine percent of patients responded “Disagree/Strongly
Disagree” to the statement “My pump was not disconnected for more
than 1 hour” (Table 3).
In exploring the association between patient satisfaction and
various clinical characteristics, the results revealed that there is a
significant association between HbA1c level and patient satisfaction (p
= 0.01), however, due to the small sample size, these results should be
viewed with caution.

Strongly
Disagree

Disagree

Neutral

Agree

Strongly
Agree

1

8/16.7

2

4/8.33

6/12.5

4/8.33

17/35.4

13/27.1

7/14.6

11/23.0

17/35.4

3

9/19.0

6/13.0

2/4.26

2/4.26

14/30.0

23/49.0

4

42/88.0

2/4.20

2/4.20

5

4/9.52

3/7.14

8/19.1

8/19.1

19/45.2

6

11/23.0

3/6.30

12/25.0

22/46.0

7

2/4.35

4/8.70

16/34.8

22/47.8

8

1/2.22

1/2.22

12/26.7

31/69.0

9

3/6.40

1/2.13

20/42.6

23/49.0

4/8.33

15/31.3

29/60.0

17/34.0

12/24.0

Question

10

2/4.20

2/4.35

11

8/16.0

4/8.00

9/18.0

Conclusions

12

6/16.2

2/5.41

10/27.0

8/21.6

11/30.0

Overall, the care provided by the hospital staff and use of CSII
during hospital admission was rated as favorable, more often than
not, on every measure of patient satisfaction. Moreover, the goal
of minimizing adverse events was met given that ninety percent
of the respondents reported having none. Increasing the patients’
awareness of the hospital’s insulin pump policy and reconnecting
the patients’ pump sooner while in the hospital were areas identified
for improvement. All patients who participated in this survey were
maintained on CSII therapy and in accordance with our current insulin
pump policy, if patients preferred to not utilize CSII in the hospital, a
basal/bolus insulin regimen would have been utilized (Table 4).

13

3/6.70

3/6.70

12/27.0

11/24.0

15/36.0

14

32/64.0

1/2.00

5/10.0

2/4.00

10/20.0

3/6.00

8/16.0

18/36.0

21/42.0

3/6.12

10/24.0

35/71.0

17

1/2.00

12/24.5

36/73.5

18

4/8.33

13/27.1

31/65.0

The areas in which patients were satisfied were: being asked about
their basal and bolus rates, the ease of getting insulin for a reservoir
change, getting the self-assesment and patient attestation forms, and
the endocrinologist’s ability to manage their pump. Areas identified
as needing improvement is the emergency room awareness of the
protocol and improving the transition for patients when they are going
for procedures requiring pump disconnection.
The primary purpose of our study was to determine the current
level of patient satisfaction with regard to the patient experience and
he CSII pump utilization at our institution and to identify areas for
improvement. It has also allowed us, as an inpatient diabetes team, to
target our educational initiatives towards theses identified areas. We
have since met with the emergency room staff and agreed that they
should call an endocrine consult for patients admitted with insulin
pumps that require any radiological study, surgery, diabetic ketoQuestion 1

Frequency

Percent

Cumulative Cumulative
Frequency
Percent

Strongly Disagree

8

16.67

8

Disagree

6

12.50

14

16.7
29.2

Neutral

4

8.30

18

37.5

Agree

17

35.42

35

72.9

Strongly Agree

33

27.08

48

100

Frequency Missing = 2
Table 2: The staff in the ED made me aware of the hospital insulin pump policy.
Question 6

Frequency

Percent

Cumulative
Frequency

Cumulative
Percent

Strongly Disagree

11

22.92

11

22.9

Disagree

3

6.25

14

29.2

Agree

12

25.00

26

54.2

Strongly Agree

22

45.83

48

100

Frequency Missing = 2
Table 3: My pump was disconnected for more than 1 hour.
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15
16

1/2.00

19

1/2.00

3/6.00

1/2.00

12/24.0

33/66.0

20

4/8.20

6/12.2

3/6.12

11/22.5

25/51.0

Table 4: Summary table for survey question responses (Frequency/Percent).

acidosis or have an inability to manage their pump. In addition, we
have met with the radiology department to ensure their familiarity
with the policy. Although the relationship between patient satisfaction,
health care utilization and outcomes remains poorly defined, patient
satisfaction data may be used to evaluate physicians and determine
incentive-based compensation. [14-18].
All patients were encouraged to answer freely and we recognized
that favorable responses to the majority of questionnaire items could
be attributed to selection bias of the participants as we conducted an
observational cross-sectional study and many of the patients were
managed by one member of the inpatient diabetes team. Future studies
may benefit from anonymous submission of questionnaire answers.
Perhaps if patients could take the survey multiple times during their
admission or during repeat admissions, the results would have been
different. Another limitation is that our current survey is written in
English only. Therefore, only those patients who read and write English
fluently were eligible for participation. Finally, a larger sample size
would have contributed to the variability and increased precision of
the findings. The number of patients using CSII is generally small as
compared to those who use subcutaneous insulin. From January 2015
to mid-June 2015, there have been 71 admissions in which a patient
had an insulin pump ordered in our electronic medical record.
For further studies, it will be interesting to look at patient
satisfaction over a longer period of time and across different health
institutions. Revisions to our questionnaire will be based on this pilot
survey and will be used for our next project, as we plan to distribute the
revised version to our sister institution which is also Joint Commission
Certified in Inpatient Diabetes: Long Island Jewish Hospital. These
efforts will allow us to assess for inter-hospital variability and determine
the validity of this tool in assessing inpatient insulin pump care.
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